

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 6.17457333 |
| 2 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.97024373 |
| 3 | vocalization behavior (GO:0071625) | 5.64344592 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 5.56098963 |
| 5 | presynaptic membrane organization (GO:0097090) | 5.53854431 |
| 6 | protein localization to synapse (GO:0035418) | 5.37540020 |
| 7 | postsynaptic membrane organization (GO:0001941) | 5.32674766 |
| 8 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.31098824 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.14803212 |
| 10 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.13162863 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.13045495 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.07600554 |
| 13 | glutamate receptor signaling pathway (GO:0007215) | 4.98322509 |
| 14 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.95344969 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 4.92489737 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.91393728 |
| 17 | glutamate secretion (GO:0014047) | 4.69792318 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.69182211 |
| 19 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.67261705 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.63056104 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.55735587 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.47053891 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.46810549 |
| 24 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.38129642 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 4.26545219 |
| 26 | positive regulation of dendritic spine development (GO:0060999) | 4.18168732 |
| 27 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.14386040 |
| 28 | neuron recognition (GO:0008038) | 4.13316305 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 4.13186498 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.13092959 |
| 31 | sodium ion export (GO:0071436) | 4.10418372 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 4.06881302 |
| 33 | startle response (GO:0001964) | 4.05993927 |
| 34 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.02768669 |
| 35 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.98581370 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.97033371 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.96786666 |
| 38 | long-term synaptic potentiation (GO:0060291) | 3.94050588 |
| 39 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.90324331 |
| 40 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.85421957 |
| 41 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.80742382 |
| 42 | gamma-aminobutyric acid transport (GO:0015812) | 3.77732675 |
| 43 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.71348317 |
| 44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.66796420 |
| 45 | cerebellar granule cell differentiation (GO:0021707) | 3.65780247 |
| 46 | response to histamine (GO:0034776) | 3.62953324 |
| 47 | exploration behavior (GO:0035640) | 3.61597613 |
| 48 | axonal fasciculation (GO:0007413) | 3.61290515 |
| 49 | locomotory exploration behavior (GO:0035641) | 3.59120533 |
| 50 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.57626786 |
| 51 | mechanosensory behavior (GO:0007638) | 3.57165711 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.56816231 |
| 53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.55702622 |
| 54 | positive regulation of synapse assembly (GO:0051965) | 3.53819388 |
| 55 | L-amino acid import (GO:0043092) | 3.52640000 |
| 56 | nucleobase catabolic process (GO:0046113) | 3.52289179 |
| 57 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.49308968 |
| 58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.49183975 |
| 59 | cochlea development (GO:0090102) | 3.47934185 |
| 60 | innervation (GO:0060384) | 3.47926837 |
| 61 | positive regulation of membrane potential (GO:0045838) | 3.45870508 |
| 62 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.44317034 |
| 63 | serotonin metabolic process (GO:0042428) | 3.44224011 |
| 64 | regulation of vesicle fusion (GO:0031338) | 3.42707243 |
| 65 | regulation of synapse maturation (GO:0090128) | 3.39381688 |
| 66 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.38941256 |
| 67 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.35392249 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.35343399 |
| 69 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.34348572 |
| 70 | neurotransmitter secretion (GO:0007269) | 3.34342806 |
| 71 | regulation of glutamate secretion (GO:0014048) | 3.34167620 |
| 72 | behavioral fear response (GO:0001662) | 3.33559252 |
| 73 | behavioral defense response (GO:0002209) | 3.33559252 |
| 74 | serotonin receptor signaling pathway (GO:0007210) | 3.31803088 |
| 75 | dendritic spine morphogenesis (GO:0060997) | 3.30528526 |
| 76 | regulation of neurotransmitter transport (GO:0051588) | 3.30358685 |
| 77 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.29805863 |
| 78 | fear response (GO:0042596) | 3.28533840 |
| 79 | auditory behavior (GO:0031223) | 3.25439997 |
| 80 | regulation of neurotransmitter levels (GO:0001505) | 3.22523704 |
| 81 | synaptic vesicle endocytosis (GO:0048488) | 3.22345163 |
| 82 | regulation of dendritic spine development (GO:0060998) | 3.22023102 |
| 83 | membrane depolarization (GO:0051899) | 3.21758707 |
| 84 | regulation of axon regeneration (GO:0048679) | 3.20540279 |
| 85 | regulation of neuron projection regeneration (GO:0070570) | 3.20540279 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.20494119 |
| 87 | behavioral response to cocaine (GO:0048148) | 3.16450788 |
| 88 | regulation of neurotransmitter secretion (GO:0046928) | 3.15763554 |
| 89 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15643501 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.14721533 |
| 91 | regulation of synapse assembly (GO:0051963) | 3.14674630 |
| 92 | long-term memory (GO:0007616) | 3.13597560 |
| 93 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.12737841 |
| 94 | synaptic vesicle maturation (GO:0016188) | 3.12398509 |
| 95 | synapse assembly (GO:0007416) | 3.12079364 |
| 96 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.09821981 |
| 97 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.09821981 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 3.09505108 |
| 99 | regulation of Rac GTPase activity (GO:0032314) | 3.09183591 |
| 100 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.09171824 |
| 101 | negative regulation of dendrite development (GO:2000171) | 3.06622590 |
| 102 | response to nerve growth factor (GO:1990089) | 3.06474420 |
| 103 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.06474420 |
| 104 | establishment of nucleus localization (GO:0040023) | 3.05578285 |
| 105 | dendrite morphogenesis (GO:0048813) | 3.05253484 |
| 106 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.03969260 |
| 107 | transferrin transport (GO:0033572) | 3.03856237 |
| 108 | positive regulation of potassium ion transport (GO:0043268) | 3.03405767 |
| 109 | activation of protein kinase A activity (GO:0034199) | 3.03326406 |
| 110 | learning (GO:0007612) | 3.02944239 |
| 111 | adult walking behavior (GO:0007628) | 3.02943155 |
| 112 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99903009 |
| 113 | regulation of respiratory system process (GO:0044065) | 2.99712366 |
| 114 | neuromuscular synaptic transmission (GO:0007274) | 2.99439716 |
| 115 | regulation of dendrite morphogenesis (GO:0048814) | 2.98532005 |
| 116 | detection of calcium ion (GO:0005513) | 2.96435302 |
| 117 | amino acid import (GO:0043090) | 2.94999299 |
| 118 | primary amino compound metabolic process (GO:1901160) | 2.94668029 |
| 119 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94516433 |
| 120 | potassium ion import (GO:0010107) | 2.94347571 |
| 121 | membrane depolarization during action potential (GO:0086010) | 2.92568740 |
| 122 | synaptic transmission (GO:0007268) | 2.92117564 |
| 123 | sleep (GO:0030431) | 2.90371198 |
| 124 | membrane assembly (GO:0071709) | 2.90049721 |
| 125 | regulation of synaptic transmission (GO:0050804) | 2.89149966 |
| 126 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.86980718 |
| 127 | neurotransmitter transport (GO:0006836) | 2.86668938 |
| 128 | positive regulation of synaptic transmission (GO:0050806) | 2.86661864 |
| 129 | dendrite development (GO:0016358) | 2.86460087 |
| 130 | ferric iron transport (GO:0015682) | 2.82909893 |
| 131 | trivalent inorganic cation transport (GO:0072512) | 2.82909893 |
| 132 | regulation of synapse organization (GO:0050807) | 2.81757991 |
| 133 | long term synaptic depression (GO:0060292) | 2.81455652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.60310814 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.89337335 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02655948 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96809743 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91716727 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.71593573 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62284774 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.48567900 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42904847 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42407280 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42407280 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41840137 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39766346 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.39078878 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38510126 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36308569 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36142395 |
| 18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.32629521 |
| 19 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.27230140 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17290082 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11660627 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11516875 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 2.06394387 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.05092573 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.05001545 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 2.01629901 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96513424 |
| 28 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.96379532 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.92082801 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.90253842 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89574884 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88462880 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.82417617 |
| 34 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81513422 |
| 35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.80988502 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78358076 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76161827 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69972730 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69023496 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68557648 |
| 41 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.66845226 |
| 42 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.62452097 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62388631 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62331889 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.60691681 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59115325 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55574562 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55083132 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53378756 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52243369 |
| 51 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.49825873 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48624211 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47183404 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46999088 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44479333 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43553315 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41849444 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38625178 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38236916 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37474787 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35948112 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33817384 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.33494546 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33482310 |
| 65 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29510428 |
| 66 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.28741847 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28246533 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26460414 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24243666 |
| 70 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.24233084 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23775586 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23467083 |
| 73 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23009217 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22413085 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20019454 |
| 76 | * JUN_21703547_ChIP-Seq_K562_Human | 1.18529045 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18486160 |
| 78 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18244007 |
| 79 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17296680 |
| 80 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17228377 |
| 81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16958293 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15478261 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14042636 |
| 84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13970563 |
| 85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13798738 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13413263 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11847626 |
| 88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10295555 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09287520 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09065026 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08121711 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06882995 |
| 93 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06359004 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06295375 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06269556 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06269556 |
| 97 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05584496 |
| 98 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03795244 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03691538 |
| 100 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03660852 |
| 101 | * AR_19668381_ChIP-Seq_PC3_Human | 1.03265662 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02306736 |
| 103 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.02030751 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01905286 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00713788 |
| 106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99943413 |
| 107 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99345113 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99335831 |
| 109 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99262104 |
| 110 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98937942 |
| 111 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98631693 |
| 112 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96413289 |
| 113 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95420950 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94784332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 6.88120093 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.50404170 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.84593790 |
| 4 | MP0004270_analgesia | 3.79882075 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.38392564 |
| 6 | MP0009745_abnormal_behavioral_response | 3.30425555 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.27373810 |
| 8 | MP0002736_abnormal_nociception_after | 3.07603794 |
| 9 | MP0002064_seizures | 2.95315404 |
| 10 | MP0002735_abnormal_chemical_nociception | 2.89968347 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.88265409 |
| 12 | MP0009046_muscle_twitch | 2.71253053 |
| 13 | MP0002272_abnormal_nervous_system | 2.55562880 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.45917251 |
| 15 | MP0001440_abnormal_grooming_behavior | 2.35286887 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.31484209 |
| 17 | MP0001486_abnormal_startle_reflex | 2.26330910 |
| 18 | MP0002067_abnormal_sensory_capabilities | 2.19105356 |
| 19 | MP0001188_hyperpigmentation | 2.17345934 |
| 20 | MP0003787_abnormal_imprinting | 2.11451340 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.01751018 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 2.00994605 |
| 23 | MP0003879_abnormal_hair_cell | 2.00102077 |
| 24 | MP0000778_abnormal_nervous_system | 1.86363673 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.83465740 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.78876669 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.78544559 |
| 28 | MP0002184_abnormal_innervation | 1.77566312 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.74522618 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.73851652 |
| 31 | MP0001970_abnormal_pain_threshold | 1.71763716 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.71396638 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.62311967 |
| 34 | MP0001529_abnormal_vocalization | 1.62012075 |
| 35 | MP0003329_amyloid_beta_deposits | 1.54097391 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.48713030 |
| 37 | MP0004924_abnormal_behavior | 1.48713030 |
| 38 | MP0001984_abnormal_olfaction | 1.46644504 |
| 39 | MP0004858_abnormal_nervous_system | 1.43962994 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.43680001 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.41000237 |
| 42 | MP0005171_absent_coat_pigmentation | 1.39411010 |
| 43 | MP0008569_lethality_at_weaning | 1.31676546 |
| 44 | MP0000955_abnormal_spinal_cord | 1.31250107 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.30790378 |
| 46 | MP0001905_abnormal_dopamine_level | 1.30487855 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.30014410 |
| 48 | MP0003122_maternal_imprinting | 1.29805100 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.27599485 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.24835936 |
| 51 | MP0004142_abnormal_muscle_tone | 1.23651041 |
| 52 | MP0002882_abnormal_neuron_morphology | 1.23442975 |
| 53 | MP0004742_abnormal_vestibular_system | 1.21197038 |
| 54 | MP0005409_darkened_coat_color | 1.14865203 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.14330651 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.13870121 |
| 57 | MP0000920_abnormal_myelination | 1.12663020 |
| 58 | MP0001963_abnormal_hearing_physiology | 1.11297155 |
| 59 | MP0003633_abnormal_nervous_system | 1.08717849 |
| 60 | MP0003136_yellow_coat_color | 1.05751918 |
| 61 | MP0002822_catalepsy | 1.04601989 |
| 62 | MP0004484_altered_response_of | 0.98480431 |
| 63 | MP0002653_abnormal_ependyma_morphology | 0.98269936 |
| 64 | MP0001485_abnormal_pinna_reflex | 0.96223399 |
| 65 | MP0003631_nervous_system_phenotype | 0.92382365 |
| 66 | MP0003690_abnormal_glial_cell | 0.92353272 |
| 67 | MP0002152_abnormal_brain_morphology | 0.91490737 |
| 68 | MP0000026_abnormal_inner_ear | 0.86330207 |
| 69 | MP0002229_neurodegeneration | 0.86251959 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.86247412 |
| 71 | MP0004130_abnormal_muscle_cell | 0.85508482 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 0.82742510 |
| 73 | MP0004085_abnormal_heartbeat | 0.82511931 |
| 74 | MP0002069_abnormal_eating/drinking_beha | 0.82357906 |
| 75 | MP0001664_abnormal_digestion | 0.81943503 |
| 76 | MP0000751_myopathy | 0.81505816 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.81068307 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.79616162 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.79502461 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.78830906 |
| 81 | MP0008877_abnormal_DNA_methylation | 0.76520113 |
| 82 | MP0004885_abnormal_endolymph | 0.76188357 |
| 83 | MP0005535_abnormal_body_temperature | 0.75721589 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.74931285 |
| 85 | MP0004147_increased_porphyrin_level | 0.72053414 |
| 86 | MP0002102_abnormal_ear_morphology | 0.71410693 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.69330169 |
| 88 | MP0008874_decreased_physiological_sensi | 0.68688567 |
| 89 | MP0003861_abnormal_nervous_system | 0.67759005 |
| 90 | MP0009379_abnormal_foot_pigmentation | 0.66407388 |
| 91 | MP0004043_abnormal_pH_regulation | 0.66257541 |
| 92 | MP0010769_abnormal_survival | 0.65679038 |
| 93 | MP0008872_abnormal_physiological_respon | 0.64460032 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.63933292 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.63771672 |
| 96 | MP0010770_preweaning_lethality | 0.63153373 |
| 97 | MP0002082_postnatal_lethality | 0.63153373 |
| 98 | MP0010768_mortality/aging | 0.62122850 |
| 99 | MP0000604_amyloidosis | 0.61495971 |
| 100 | MP0003121_genomic_imprinting | 0.60846148 |
| 101 | MP0002249_abnormal_larynx_morphology | 0.59824759 |
| 102 | MP0002163_abnormal_gland_morphology | 0.57681968 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.56552231 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.56325221 |
| 105 | MP0001943_abnormal_respiration | 0.55295384 |
| 106 | MP0003938_abnormal_ear_development | 0.53484963 |
| 107 | MP0003632_abnormal_nervous_system | 0.53152508 |
| 108 | MP0005499_abnormal_olfactory_system | 0.51602599 |
| 109 | MP0005394_taste/olfaction_phenotype | 0.51602599 |
| 110 | MP0003634_abnormal_glial_cell | 0.51568021 |
| 111 | MP0003956_abnormal_body_size | 0.50820407 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.49918483 |
| 113 | MP0008004_abnormal_stomach_pH | 0.49694148 |
| 114 | MP0005187_abnormal_penis_morphology | 0.49226474 |
| 115 | MP0000678_abnormal_parathyroid_gland | 0.48891907 |
| 116 | MP0001177_atelectasis | 0.48836398 |
| 117 | MP0003123_paternal_imprinting | 0.48518622 |
| 118 | MP0005595_abnormal_vascular_smooth | 0.48318730 |
| 119 | MP0005253_abnormal_eye_physiology | 0.45597578 |
| 120 | MP0002081_perinatal_lethality | 0.43670605 |
| 121 | MP0002873_normal_phenotype | 0.43171201 |
| 122 | MP0002169_no_abnormal_phenotype | 0.42348177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.75898821 |
| 2 | Epileptic encephalopathy (HP:0200134) | 6.58219354 |
| 3 | Hyperventilation (HP:0002883) | 6.38747277 |
| 4 | Atonic seizures (HP:0010819) | 5.91365387 |
| 5 | Focal seizures (HP:0007359) | 5.38463039 |
| 6 | Febrile seizures (HP:0002373) | 5.35056091 |
| 7 | Absence seizures (HP:0002121) | 4.58148004 |
| 8 | Myokymia (HP:0002411) | 4.54020607 |
| 9 | Dialeptic seizures (HP:0011146) | 4.34802725 |
| 10 | Broad-based gait (HP:0002136) | 4.04499514 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.79302833 |
| 12 | Ankle clonus (HP:0011448) | 3.77397333 |
| 13 | Visual hallucinations (HP:0002367) | 3.77102148 |
| 14 | Amblyopia (HP:0000646) | 3.69812110 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.61757482 |
| 16 | Spastic gait (HP:0002064) | 3.51146424 |
| 17 | Drooling (HP:0002307) | 3.34689288 |
| 18 | Excessive salivation (HP:0003781) | 3.34689288 |
| 19 | Protruding tongue (HP:0010808) | 3.34582649 |
| 20 | Epileptiform EEG discharges (HP:0011182) | 3.25058757 |
| 21 | Papilledema (HP:0001085) | 3.17839117 |
| 22 | Long nose (HP:0003189) | 3.15119679 |
| 23 | Urinary urgency (HP:0000012) | 3.10156295 |
| 24 | Abnormal hair whorl (HP:0010721) | 2.95000887 |
| 25 | Mutism (HP:0002300) | 2.90451759 |
| 26 | Lower limb muscle weakness (HP:0007340) | 2.89892118 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 2.88662879 |
| 28 | Intention tremor (HP:0002080) | 2.87703760 |
| 29 | Hemiplegia (HP:0002301) | 2.87221483 |
| 30 | Poor eye contact (HP:0000817) | 2.81832724 |
| 31 | Absent speech (HP:0001344) | 2.79140909 |
| 32 | Inability to walk (HP:0002540) | 2.78840948 |
| 33 | Conical tooth (HP:0000698) | 2.77550134 |
| 34 | Limb dystonia (HP:0002451) | 2.74672523 |
| 35 | Blue irides (HP:0000635) | 2.70378126 |
| 36 | Truncal ataxia (HP:0002078) | 2.66467231 |
| 37 | Gait imbalance (HP:0002141) | 2.64451927 |
| 38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.62358396 |
| 39 | Postural instability (HP:0002172) | 2.57176070 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.53807900 |
| 41 | Fair hair (HP:0002286) | 2.53508934 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.52471623 |
| 43 | Torticollis (HP:0000473) | 2.52151403 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.51164683 |
| 45 | Dysdiadochokinesis (HP:0002075) | 2.48924464 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 2.47828350 |
| 47 | Fetal akinesia sequence (HP:0001989) | 2.47537282 |
| 48 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.46272230 |
| 49 | Dysmetria (HP:0001310) | 2.43007621 |
| 50 | Diplopia (HP:0000651) | 2.42789000 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.42789000 |
| 52 | Spastic tetraparesis (HP:0001285) | 2.42113037 |
| 53 | Congenital primary aphakia (HP:0007707) | 2.41811250 |
| 54 | Thickened helices (HP:0000391) | 2.41333376 |
| 55 | Abnormal social behavior (HP:0012433) | 2.40208762 |
| 56 | Impaired social interactions (HP:0000735) | 2.40208762 |
| 57 | Anxiety (HP:0000739) | 2.39958782 |
| 58 | Amyotrophic lateral sclerosis (HP:0007354) | 2.38161957 |
| 59 | Abnormality of salivation (HP:0100755) | 2.35415849 |
| 60 | Abnormality of the lower motor neuron (HP:0002366) | 2.34302804 |
| 61 | Pheochromocytoma (HP:0002666) | 2.34033778 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.33608274 |
| 63 | Cerebral hypomyelination (HP:0006808) | 2.32599335 |
| 64 | Abnormal EKG (HP:0003115) | 2.30576130 |
| 65 | Polyphagia (HP:0002591) | 2.27700878 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.24496646 |
| 67 | Progressive macrocephaly (HP:0004481) | 2.24375100 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.23227283 |
| 69 | Hemiparesis (HP:0001269) | 2.22035480 |
| 70 | Scanning speech (HP:0002168) | 2.21265757 |
| 71 | Status epilepticus (HP:0002133) | 2.20220232 |
| 72 | Delusions (HP:0000746) | 2.20103240 |
| 73 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19679782 |
| 74 | Absent/shortened dynein arms (HP:0200106) | 2.19679782 |
| 75 | Termporal pattern (HP:0011008) | 2.19218344 |
| 76 | Insidious onset (HP:0003587) | 2.19218344 |
| 77 | Stereotypic behavior (HP:0000733) | 2.18040145 |
| 78 | Supranuclear gaze palsy (HP:0000605) | 2.18035974 |
| 79 | Generalized hypopigmentation of hair (HP:0011358) | 2.17962255 |
| 80 | Impaired smooth pursuit (HP:0007772) | 2.16554865 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.16037676 |
| 82 | Action tremor (HP:0002345) | 2.15617458 |
| 83 | Intellectual disability, severe (HP:0010864) | 2.15209585 |
| 84 | Akinesia (HP:0002304) | 2.14432785 |
| 85 | Neurofibrillary tangles (HP:0002185) | 2.11922776 |
| 86 | Absent eyebrow (HP:0002223) | 2.10484780 |
| 87 | Neuroendocrine neoplasm (HP:0100634) | 2.10281885 |
| 88 | Tetraplegia (HP:0002445) | 2.09262559 |
| 89 | Megalencephaly (HP:0001355) | 2.08408553 |
| 90 | Genital tract atresia (HP:0001827) | 2.08329288 |
| 91 | Prolonged QT interval (HP:0001657) | 2.08296739 |
| 92 | Vaginal atresia (HP:0000148) | 2.07003024 |
| 93 | Clonus (HP:0002169) | 2.04311296 |
| 94 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.03414998 |
| 95 | Depression (HP:0000716) | 2.02397649 |
| 96 | Focal dystonia (HP:0004373) | 2.01369235 |
| 97 | Generalized myoclonic seizures (HP:0002123) | 2.00949234 |
| 98 | Progressive inability to walk (HP:0002505) | 2.00431824 |
| 99 | Gastroesophageal reflux (HP:0002020) | 2.00198062 |
| 100 | Heterochromia iridis (HP:0001100) | 1.99761981 |
| 101 | Syncope (HP:0001279) | 1.98962480 |
| 102 | Incomplete penetrance (HP:0003829) | 1.98377541 |
| 103 | Short tibia (HP:0005736) | 1.96867882 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 1.95862171 |
| 105 | Muscular hypotonia of the trunk (HP:0008936) | 1.95455912 |
| 106 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.94102020 |
| 107 | Annular pancreas (HP:0001734) | 1.92479869 |
| 108 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.91624138 |
| 109 | Exotropia (HP:0000577) | 1.91265443 |
| 110 | Bradykinesia (HP:0002067) | 1.91053257 |
| 111 | Retinal dysplasia (HP:0007973) | 1.90994570 |
| 112 | Lissencephaly (HP:0001339) | 1.89414988 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88476522 |
| 114 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88476522 |
| 115 | Hydroureter (HP:0000072) | 1.87513917 |
| 116 | Memory impairment (HP:0002354) | 1.84736434 |
| 117 | Spastic tetraplegia (HP:0002510) | 1.84437630 |
| 118 | Pachygyria (HP:0001302) | 1.83986379 |
| 119 | Dysautonomia (HP:0002459) | 1.83679823 |
| 120 | Decreased circulating renin level (HP:0003351) | 1.83482403 |
| 121 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82379653 |
| 122 | Abnormality of alanine metabolism (HP:0010916) | 1.82379653 |
| 123 | Hyperalaninemia (HP:0003348) | 1.82379653 |
| 124 | Oligodontia (HP:0000677) | 1.81830809 |
| 125 | Acute encephalopathy (HP:0006846) | 1.80456510 |
| 126 | Poor suck (HP:0002033) | 1.80354890 |
| 127 | Widely spaced teeth (HP:0000687) | 1.79893218 |
| 128 | Poor coordination (HP:0002370) | 1.79670850 |
| 129 | Hyperthyroidism (HP:0000836) | 1.79103742 |
| 130 | Lower limb amyotrophy (HP:0007210) | 1.78942525 |
| 131 | Narrow nasal bridge (HP:0000446) | 1.78641826 |
| 132 | Esotropia (HP:0000565) | 1.78320734 |
| 133 | Impaired vibratory sensation (HP:0002495) | 1.78260191 |
| 134 | Specific learning disability (HP:0001328) | 1.77379029 |
| 135 | Psychosis (HP:0000709) | 1.76856155 |
| 136 | Abnormality of the corticospinal tract (HP:0002492) | 1.74845081 |
| 137 | Mitochondrial inheritance (HP:0001427) | 1.74636074 |
| 138 | Inappropriate behavior (HP:0000719) | 1.73821416 |
| 139 | Neoplasm of the oral cavity (HP:0100649) | 1.73476178 |
| 140 | Clumsiness (HP:0002312) | 1.72731529 |
| 141 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.71813082 |
| 142 | Preaxial foot polydactyly (HP:0001841) | 1.70759789 |
| 143 | Sleep apnea (HP:0010535) | 1.70581946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.99377457 |
| 2 | EPHA4 | 5.04339567 |
| 3 | NTRK3 | 4.80335864 |
| 4 | MAP2K7 | 2.95356541 |
| 5 | RIPK4 | 2.82757957 |
| 6 | MAP3K12 | 2.68467131 |
| 7 | MAP3K4 | 2.64121762 |
| 8 | PLK2 | 2.34589036 |
| 9 | CDK19 | 2.32717191 |
| 10 | DAPK2 | 2.18654739 |
| 11 | DAPK1 | 2.16238927 |
| 12 | RIPK1 | 2.08819498 |
| 13 | AKT3 | 2.05320895 |
| 14 | PRPF4B | 2.02262581 |
| 15 | MINK1 | 2.00459840 |
| 16 | TYRO3 | 1.86488266 |
| 17 | CCNB1 | 1.80210642 |
| 18 | BMPR2 | 1.77593209 |
| 19 | MAP2K4 | 1.68553336 |
| 20 | SIK3 | 1.66507016 |
| 21 | MAP3K9 | 1.61780269 |
| 22 | PNCK | 1.58910514 |
| 23 | TNIK | 1.56513718 |
| 24 | KSR1 | 1.56122222 |
| 25 | OXSR1 | 1.48976146 |
| 26 | MARK1 | 1.47753324 |
| 27 | NME1 | 1.44880239 |
| 28 | MAPK13 | 1.36545949 |
| 29 | CAMK2B | 1.25979741 |
| 30 | GRK5 | 1.25112078 |
| 31 | PRKCG | 1.25082648 |
| 32 | PTK2B | 1.24794728 |
| 33 | ARAF | 1.24546009 |
| 34 | CAMK2A | 1.22591135 |
| 35 | SIK2 | 1.20966216 |
| 36 | CDK5 | 1.12587615 |
| 37 | PAK6 | 1.12176209 |
| 38 | VRK1 | 1.09662888 |
| 39 | KSR2 | 1.08581821 |
| 40 | SGK2 | 1.08091313 |
| 41 | NTRK2 | 1.07086104 |
| 42 | TAOK3 | 1.04549808 |
| 43 | PINK1 | 1.03473942 |
| 44 | NTRK1 | 1.02862530 |
| 45 | SGK494 | 0.97907649 |
| 46 | SGK223 | 0.97907649 |
| 47 | BCR | 0.93916615 |
| 48 | CAMK4 | 0.92354652 |
| 49 | RAF1 | 0.89946321 |
| 50 | GRK7 | 0.87017039 |
| 51 | BRAF | 0.86478696 |
| 52 | FGR | 0.86092049 |
| 53 | LATS2 | 0.84652113 |
| 54 | FES | 0.84565027 |
| 55 | CAMKK2 | 0.84241123 |
| 56 | MAP3K13 | 0.80188523 |
| 57 | PRKCZ | 0.75773927 |
| 58 | TNK2 | 0.72556782 |
| 59 | PRKCE | 0.72522090 |
| 60 | SGK1 | 0.70706852 |
| 61 | CDC42BPA | 0.69516779 |
| 62 | FER | 0.68905143 |
| 63 | CDK18 | 0.67206084 |
| 64 | CAMKK1 | 0.66691909 |
| 65 | DYRK2 | 0.65797881 |
| 66 | PRKCH | 0.65283957 |
| 67 | FRK | 0.64287202 |
| 68 | TRIM28 | 0.63449874 |
| 69 | CDK15 | 0.58365865 |
| 70 | CAMK1 | 0.57767430 |
| 71 | CAMK2D | 0.57438917 |
| 72 | CDK14 | 0.56604614 |
| 73 | TGFBR2 | 0.55404898 |
| 74 | MAP2K6 | 0.54794035 |
| 75 | DYRK1A | 0.53721357 |
| 76 | SGK3 | 0.52982258 |
| 77 | MAPK15 | 0.52757528 |
| 78 | MARK2 | 0.52667665 |
| 79 | PDK3 | 0.49466329 |
| 80 | PDK4 | 0.49466329 |
| 81 | CDK11A | 0.48874210 |
| 82 | ADRBK2 | 0.48121527 |
| 83 | MAP2K1 | 0.47950690 |
| 84 | PAK3 | 0.47549337 |
| 85 | MAP3K2 | 0.47048516 |
| 86 | CDK3 | 0.45813886 |
| 87 | DMPK | 0.43408232 |
| 88 | MAPK12 | 0.43263858 |
| 89 | INSRR | 0.42700894 |
| 90 | MAPK7 | 0.42179923 |
| 91 | STK38 | 0.42143236 |
| 92 | UHMK1 | 0.41359794 |
| 93 | CAMK2G | 0.41330893 |
| 94 | PRKD3 | 0.40821518 |
| 95 | FYN | 0.40100865 |
| 96 | BMPR1B | 0.39725324 |
| 97 | ROCK2 | 0.39173232 |
| 98 | MAP4K2 | 0.39157098 |
| 99 | GRK6 | 0.38590777 |
| 100 | WNK3 | 0.38417494 |
| 101 | MAP3K11 | 0.37175145 |
| 102 | ADRBK1 | 0.37079052 |
| 103 | CAMK1G | 0.36852862 |
| 104 | MAP3K6 | 0.36582120 |
| 105 | PRKACA | 0.35608847 |
| 106 | MKNK2 | 0.34610050 |
| 107 | STK11 | 0.34451528 |
| 108 | PRKG1 | 0.34426325 |
| 109 | PIK3CA | 0.34395975 |
| 110 | MAPK10 | 0.34161071 |
| 111 | PRKCQ | 0.33854212 |
| 112 | CSNK1G2 | 0.33269088 |
| 113 | CSNK1D | 0.32830841 |
| 114 | NEK6 | 0.32810810 |
| 115 | TSSK6 | 0.32634081 |
| 116 | DAPK3 | 0.32138071 |
| 117 | PDGFRB | 0.32024120 |
| 118 | ROCK1 | 0.31250422 |
| 119 | MYLK | 0.31213872 |
| 120 | PKN1 | 0.29839471 |
| 121 | PRKCB | 0.29625612 |
| 122 | PDPK1 | 0.28951293 |
| 123 | STK39 | 0.28125721 |
| 124 | PRKCA | 0.27996390 |
| 125 | MAP3K1 | 0.27327348 |
| 126 | PDK1 | 0.27187960 |
| 127 | RET | 0.27151498 |
| 128 | PHKG2 | 0.26946710 |
| 129 | PHKG1 | 0.26946710 |
| 130 | RPS6KA3 | 0.26927183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.85809331 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 3.21703883 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12256581 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.08135946 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.89493182 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.82216763 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.68702140 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67173156 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.51587451 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.46065358 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.33816638 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.30095695 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.22683437 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15861119 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.06500915 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 2.05409413 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.89541406 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.86677894 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.83649815 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66573399 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66430681 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64392189 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64302943 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62534744 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59604983 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.54491697 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.52099885 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42637999 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35052810 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31775332 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.25592383 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.24010245 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22900436 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21957253 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.21665541 |
| 36 | Axon guidance_Homo sapiens_hsa04360 | 1.21439934 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19490790 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15572180 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11727857 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06202378 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03601274 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02215887 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01052265 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96952017 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 0.95813054 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94320523 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93697922 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91312719 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85742509 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85738047 |
| 51 | Glioma_Homo sapiens_hsa05214 | 0.84035986 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80571980 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78339422 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77040572 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76260621 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75197482 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72107884 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67350869 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63991596 |
| 60 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63248227 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61097029 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60100467 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57936736 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57134694 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56481858 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56243878 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.55994877 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55704742 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54534515 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52582260 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51612222 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51494921 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.50629427 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49661346 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48918063 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47939321 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47828484 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44970964 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41895851 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41784873 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41759739 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41221227 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40128691 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39982518 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39816507 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39409931 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38705349 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37800065 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36425674 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36410192 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35665078 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35231858 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.31807754 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30327612 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29971858 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.28582836 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28549728 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27711287 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27169840 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26876407 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.26377303 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25917037 |
| 103 | Melanoma_Homo sapiens_hsa05218 | 0.25552205 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24871345 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24612758 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24428346 |
| 107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.23920465 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23057221 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22119206 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19957498 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.19224006 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19208049 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.18400327 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17384575 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.17327427 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17014078 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16636201 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15845898 |
| 119 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.15296396 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12521666 |

